AI assistant
Sending…
Sanofi — Director's Dealing 2015
Nov 5, 2015
1643_dirs_2015-11-05_b66d6877-0935-482e-8b7a-a3c61251b53b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MyoKardia Inc (MYOK)
CIK: 0001552451
Period of Report: 2015-11-03
Reporting Person: Sanofi (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-03 | Common stock Par value per share $ 0.0001 | C | 2318899 | — | Acquired | 2318899 | Indirect |
| 2015-11-03 | Common stock Par value per share $ 0.0001 | P | 900000 | $10 | Acquired | 3218899 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-03 | Series A-1 redeemable convertible preferred stock | $0 | C | 6666667 | Disposed | Common stocks (1814059) | Indirect | |
| 2015-11-03 | Series B redeemable convertible preferred stock | $0 | C | 1855288 | Disposed | Common stocks (504840) | Indirect |
Footnotes
F1: Conversion upon Initial Public Offering
More from Sanofi
Share Issue/Capital Change
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Report Publication Announcement
2026
May 27
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Capital/Financing Update
2026
May 18